Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation.
Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available. CR Bard, headquartered in Murray Hill, New Jersey, USA, develops, manufactures and supplies vascular, urology, oncology and surgical specialty products. Historically, Bard is renowned for its products in the urological field, where its Foley catheter is the leading device for bladder drainage.
In January 2006, Bard acquired assets from PST LLC related to self-expanding nitinol stent technology currently in development and, in March 2006, signed an agreement to acquire Venetec International, the manufacturer of the StatLock line of catheter securement systems.
Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation.